These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 4047738)

  • 41. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.
    Kawakami Y; Battles JK; Kobayashi T; Ennis W; Wang X; Tupesis JP; Marincola FM; Robbins PF; Hearing VJ; Gonda MA; Rosenberg SA
    J Immunol Methods; 1997 Mar; 202(1):13-25. PubMed ID: 9075767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the expression of Hanganutziu-Deicher (HD) antigen in human malignant melanoma.
    Kawachi S; Saida T
    J Dermatol; 1992 Nov; 19(11):827-30. PubMed ID: 1293171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.
    Watanabe T; Pukel CS; Takeyama H; Lloyd KO; Shiku H; Li LT; Travassos LR; Oettgen HF; Old LJ
    J Exp Med; 1982 Dec; 156(6):1884-9. PubMed ID: 7175442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biochemistry of melanoma-associated ganglioside antigens].
    Hirabayashi Y; Higashi H; Taniguchi M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):834-40. PubMed ID: 2421644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of differentiation antigens of melanoma and melanocytes by mouse and human monoclonal antibodies.
    Houghton AN
    Transplant Proc; 1984 Apr; 16(2):351-4. PubMed ID: 6144202
    [No Abstract]   [Full Text] [Related]  

  • 46. Structural and functional properties of ganglioside antigens on human tumors of neuroectodermal origin.
    Cheresh DA
    Surv Synth Pathol Res; 1985; 4(2):97-109. PubMed ID: 2996108
    [No Abstract]   [Full Text] [Related]  

  • 47. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.
    Esclamado RM; Gown AM; Vogel AM
    Am J Surg; 1986 Oct; 152(4):376-85. PubMed ID: 3766867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance.
    Natali PG; Roberts JT; Difilippo F; Bigotti A; Dent PB; Ferrone S; Liao SK
    Cancer; 1987 Jan; 59(1):55-63. PubMed ID: 3539308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigens and antibodies in malignant melanoma.
    Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P
    Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis: anti-ganglioside and anti-ras p21 antibodies as markers of tumor progression.
    Yamamura K; Mishima Y
    J Invest Dermatol; 1990 Feb; 94(2):174-82. PubMed ID: 2299192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigenic profile of mucosal melanoma lesions.
    Kageshita T; Kimura T; Yoshi A; Hirai S; Ono T; Ferrone S
    Int J Cancer; 1994 Feb; 56(3):370-4. PubMed ID: 8314324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
    Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
    J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunorecognition of ganglioside epitopes: correlation between affinity and cytotoxicity of ganglioside antibodies.
    Dippold W; Bernhard H
    Eur J Cancer; 1992; 28A(10):1605-10. PubMed ID: 1382491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
    Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
    J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
    Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
    Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.
    Sikora LK; Pinto A; Demetrick DJ; Dixon WT; Urbanski SJ; Temple W; Jerry LM
    Int J Cancer; 1987 Feb; 39(2):138-45. PubMed ID: 3804488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy.
    Taatjes DJ; Arendash-Durand B; von Turkovich M; Trainer TD
    Arch Pathol Lab Med; 1993 Mar; 117(3):264-8. PubMed ID: 8442672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
    Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ
    J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
    Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
    Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.